2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (U.S.). Clinical Practice Guidelines We Can Trust. ed. Washington, DC: Press NA, 2011.
Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (U.S.). Finding What Works in Health Care: Standards for Systematic Reviews. ed. Washington, DC: Press NA, 2011.
Anderson, 2014, ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2304, 10.1016/j.jacc.2014.03.016
2010, Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines, American College of Cardiology and American Heart Association
Halperin, 2016, Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 67, 1572, 10.1016/j.jacc.2015.09.001
Jacobs, 2013, ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, 213, 10.1016/j.jacc.2012.09.025
Jacobs, 2014, The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 64, 1373, 10.1016/j.jacc.2014.06.001
Nishimura, 2014, 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, 2438, 10.1016/j.jacc.2014.02.537
Nishimura, 2014, 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 63, e57, 10.1016/j.jacc.2014.02.536
Habib, 2015, 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC), Eur Heart J, 36, 3075, 10.1093/eurheartj/ehv319
Glenny, 2013, Antibiotics for the prophylaxis of bacterial endocarditis in dentistry, Cochrane Database Syst Rev, CD003813
(NICE) UNIfHaCE. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. Available at: https://www.nice.org.uk/guidance/cg64. Accessed January 20, 2017.
Mougeot, 2015, Associations between bacteremia from oral sources and distant-site infections: tooth brushing versus single tooth extraction, Oral Surg Oral Med Oral Pathol Oral Radiol, 119, 430, 10.1016/j.oooo.2015.01.009
Desimone, 2012, Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines, Circulation, 126, 60, 10.1161/CIRCULATIONAHA.112.095281
Dayer, 2015, Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis, Lancet, 385, 1219, 10.1016/S0140-6736(14)62007-9
Duval, 2012, Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys, J Am Coll Cardiol, 59, 1968, 10.1016/j.jacc.2012.02.029
Pasquali, 2012, Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines, Am Heart J, 163, 894, 10.1016/j.ahj.2012.03.002
Pant, 2015, Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011, J Am Coll Cardiol, 65, 2070, 10.1016/j.jacc.2015.03.518
Thornhill, 2011, Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study, BMJ, 342, d2392, 10.1136/bmj.d2392
Strom, 2000, Risk factors for infective endocarditis: oral hygiene and nondental exposures, Circulation, 102, 2842, 10.1161/01.CIR.102.23.2842
Sherman-Weber, 2004, Infective endocarditis following orthotopic heart transplantation: 10 cases and a review of the literature, Transpl Infect Dis, 6, 165, 10.1111/j.1399-3062.2004.00074.x
Lockhart, 2008, Bacteremia associated with toothbrushing and dental extraction, Circulation, 117, 3118, 10.1161/CIRCULATIONAHA.107.758524
Geist, 2007, American Heart Association 2007 guidelines on prevention of infective endocarditis, J Mich Dent Assoc, 89, 50
Duval, 2006, Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis, Clin Infect Dis, 42, e102, 10.1086/504385
2015, The 2015 ESC Guidelines for the management of infective endocarditis, Eur Heart J, 36, 3036
Horstkotte, 1987, Contribution for choosing the optimal prophylaxis of bacterial endocarditis, Eur Heart J, 8, 379, 10.1093/eurheartj/8.suppl_J.379
Strom, 1998, Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study, Ann Intern Med, 129, 761, 10.7326/0003-4819-129-10-199811150-00002
Amat-Santos, 2015, Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry, Circulation, 131, 1566, 10.1161/CIRCULATIONAHA.114.014089
Mangner, 2016, Incidence, predictors, and outcome of patients developing infective endocarditis following transfemoral transcatheter aortic valve replacement, J Am Coll Cardiol, 67, 2907, 10.1016/j.jacc.2016.03.588
Karavas, 2002, Risk factors and management of endocarditis after mitral valve repair, J Heart Valve Dis, 11, 660
Gillinov, 2002, Endocarditis after mitral valve repair, Ann Thorac Surg, 73, 1813, 10.1016/S0003-4975(02)03551-8
Pérez-Gómez, 2004, Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study, J Am Coll Cardiol, 44, 1557, 10.1016/j.jacc.2004.05.084
Noseworthy, 2016, Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease, Int J Cardiol, 209, 181, 10.1016/j.ijcard.2016.02.005
Avezum, 2015, Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, Circulation, 132, 624, 10.1161/CIRCULATIONAHA.114.014807
Breithardt, 2014, Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial, Eur Heart J, 35, 3377, 10.1093/eurheartj/ehu305
Ezekowitz, 2016, Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy), Circulation, 134, 589, 10.1161/CIRCULATIONAHA.115.020950
Aguilar, 2005, Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks, Cochrane Database Syst Rev, CD001927
Olesen, 2011, Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study, BMJ, 342, d124, 10.1136/bmj.d124
Lytvyn, 2016, Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: a systematic review, BMJ Open, 6, e014327, 10.1136/bmjopen-2016-014327
Horstkotte, 1988, The natural history of aortic valve stenosis, Eur Heart J, 9, 57, 10.1093/eurheartj/9.suppl_E.57
O’Brien, 2009, The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery, Ann Thorac Surg, 88, S23, 10.1016/j.athoracsur.2009.05.056
Freeman, 2005, Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies, Circulation, 111, 3316, 10.1161/CIRCULATIONAHA.104.486738
Kvidal, 2000, Observed and relative survival after aortic valve replacement, J Am Coll Cardiol, 35, 747, 10.1016/S0735-1097(99)00584-7
Murphy, 1981, Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement, Circulation, 64, II184
Rosenhek, 2012, Aortic stenosis: disease severity, progression, timing of intervention and role in monitoring transcatheter valve implanation, 425
Schwarz, 1982, The effect of aortic valve replacement on survival, Circulation, 66, 1105, 10.1161/01.CIR.66.5.1105
Adams, 2014, Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 370, 1790, 10.1056/NEJMoa1400590
Mack, 2015, 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, 385, 2477, 10.1016/S0140-6736(15)60308-7
Deeb, 2016, Three-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement, J Am Coll Cardiol, 67, 2565, 10.1016/j.jacc.2016.03.506
Holmes, 2015, Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry, J Am Coll Cardiol, 66, 2813, 10.1016/j.jacc.2015.10.021
Makkar, 2012, Transcatheter aortic-valve replacement for inoperable severe aortic stenosis, N Engl J Med, 366, 1696, 10.1056/NEJMoa1202277
Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510
Eltchaninoff, 2011, Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry, Eur Heart J, 32, 191, 10.1093/eurheartj/ehq261
Rodés-Cabau, 2012, Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience, J Am Coll Cardiol, 60, 1864, 10.1016/j.jacc.2012.08.960
Abdel-Wahab, 2015, One-year outcomes after transcatheter aortic valve replacement with balloon-expandable versus self-expandable valves: results from the CHOICE randomized clinical trial, J Am Coll Cardiol, 66, 791, 10.1016/j.jacc.2015.06.026
Kapadia, 2015, 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial, Lancet, 385, 2485, 10.1016/S0140-6736(15)60290-2
Popma, 2014, Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery, J Am Coll Cardiol, 63, 1972, 10.1016/j.jacc.2014.02.556
Leon, 2010, Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med, 363, 1597, 10.1056/NEJMoa1008232
Kodali, 2012, Two-year outcomes after transcatheter or surgical aortic-valve replacement, N Engl J Med, 366, 1686, 10.1056/NEJMoa1200384
Leon, 2016, Transcatheter or surgical aortic-valve replacement in intermediate-risk patients, N Engl J Med, 374, 1609, 10.1056/NEJMoa1514616
Thourani, 2016, Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis, Lancet, 387, 2218, 10.1016/S0140-6736(16)30073-3
Siemieniuk, 2016, Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis, BMJ, 354, i5130, 10.1136/bmj.i5130
Foroutan, 2016, Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies, BMJ, 354, i5065, 10.1136/bmj.i5065
Vandvik, 2016, Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline, BMJ, 354, i5085, 10.1136/bmj.i5085
Uretsky, 2015, Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial, J Am Coll Cardiol, 65, 1078, 10.1016/j.jacc.2014.12.047
Grayburn, 2014, Defining “severe” secondary mitral regurgitation: emphasizing an integrated approach, J Am Coll Cardiol, 64, 2792, 10.1016/j.jacc.2014.10.016
Acker, 2014, Mitral-valve repair versus replacement for severe ischemic mitral regurgitation, N Engl J Med, 370, 23, 10.1056/NEJMoa1312808
Goldstein, 2016, Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation, N Engl J Med, 374, 344, 10.1056/NEJMoa1512913
Michler, 2016, Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation, N Engl J Med, 374, 1932, 10.1056/NEJMoa1602003
Smith, 2014, Surgical treatment of moderate ischemic mitral regurgitation, N Engl J Med, 371, 2178, 10.1056/NEJMoa1410490
David, 2013, Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease, Circulation, 127, 1485, 10.1161/CIRCULATIONAHA.112.000699
Gillinov, 2010, Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop?, Ann Thorac Surg, 90, 481, 10.1016/j.athoracsur.2010.03.101
Tribouilloy, 1999, Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications, Circulation, 99, 400, 10.1161/01.CIR.99.3.400
Crawford, 1990, Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease, Circulation, 81, 1173, 10.1161/01.CIR.81.4.1173
Enriquez-Sarano, 1994, Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications, J Am Coll Cardiol, 24, 1536, 10.1016/0735-1097(94)90151-1
Grigioni, 1999, Sudden death in mitral regurgitation due to flail leaflet, J Am Coll Cardiol, 34, 2078, 10.1016/S0735-1097(99)00474-X
Grigioni, 2008, Outcomes in mitral regurgitation due to flail leaflets a multicenter European study, J Am Coll Cardiol Img, 1, 133, 10.1016/j.jcmg.2007.12.005
Schuler, 1979, Temporal response of left ventricular performance to mitral valve surgery, Circulation, 59, 1218, 10.1161/01.CIR.59.6.1218
Starling, 1995, Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation, Circulation, 92, 811, 10.1161/01.CIR.92.4.811
Tribouilloy, 2009, Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study, J Am Coll Cardiol, 54, 1961, 10.1016/j.jacc.2009.06.047
STS online risk calculator. Available at: http://riskcalcstsorg/stswebriskcalc Accessed January 20, 2017.
Braunberger, 2001, Very long-term results (more than 20 years) of valve repair with Carpentier’s techniques in nonrheumatic mitral valve insufficiency, Circulation, 104, I8, 10.1161/01.CIR.104.suppl_1.I-8
Cosgrove, 1986, Results of mitral valve reconstruction, Circulation, 74, I82
David, 1983, The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation, Circulation, 68, II76
David, 1984, Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae, J Thorac Cardiovasc Surg, 88, 718, 10.1016/S0022-5223(19)35439-X
David, 2005, A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse, J Thorac Cardiovasc Surg, 130, 1242, 10.1016/j.jtcvs.2005.06.046
Gammie, 2009, Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, Ann Thorac Surg, 87, 1431, 10.1016/j.athoracsur.2009.01.064
Goldman, 2006, Dental management of patients with bone marrow and solid organ transplantation, Dent Clin North Am, 50, 659, 10.1016/j.cden.2006.06.009
Hansen, 1989, Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance, J Thorac Cardiovasc Surg, 97, 521, 10.1016/S0022-5223(19)34542-8
Hennein, 1990, Comparative assessment of chordal preservation versus chordal resection during mitral valve replacement, J Thorac Cardiovasc Surg, 99, 828, 10.1016/S0022-5223(19)36897-7
Horskotte, 1993, The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study, J Heart Valve Dis, 2, 150
McClure, 2013, One thousand minimally invasive mitral valve operations: early outcomes, late outcomes, and echocardiographic follow-up, J Thorac Cardiovasc Surg, 145, 1199, 10.1016/j.jtcvs.2012.12.070
Rozich, 1992, Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance, Circulation, 86, 1718, 10.1161/01.CIR.86.6.1718
Rushmer, 1956, Initial phase of ventricular systole: asynchronous contraction, Am J Physiol, 184, 188, 10.1152/ajplegacy.1955.184.1.188
Sarris, 1988, Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction, J Thorac Cardiovasc Surg, 95, 969, 10.1016/S0022-5223(19)35662-4
Vassileva, 2013, Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries, Circulation, 127, 1870, 10.1161/CIRCULATIONAHA.113.002200
Badhwar, 2012, Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007, Ann Thorac Surg, 94, 1870, 10.1016/j.athoracsur.2012.05.105
Bolling, 2010, Predictors of mitral valve repair: clinical and surgeon factors, Ann Thorac Surg, 90, 1904, 10.1016/j.athoracsur.2010.07.062
Chauvaud, 2001, Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency, Circulation, 104, I12, 10.1161/hc37t1.094707
Chikwe, 2011, A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians, Eur Heart J, 32, 618, 10.1093/eurheartj/ehq331
Grossi, 1998, Valve repair versus replacement for mitral insufficiency: when is a mechanical valve still indicated?, J Thorac Cardiovasc Surg, 115, 389, 10.1016/S0022-5223(98)70283-1
Gillinov, 2003, Mitral valve repair with aortic valve replacement is superior to double valve replacement, J Thorac Cardiovasc Surg, 125, 1372, 10.1016/S0022-5223(02)73225-X
Suri, 2013, Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets, JAMA, 310, 609, 10.1001/jama.2013.8643
Rosenhek, 2006, Outcome of watchful waiting in asymptomatic severe mitral regurgitation, Circulation, 113, 2238, 10.1161/CIRCULATIONAHA.105.599175
Gillinov, 2008, Valve repair versus valve replacement for degenerative mitral valve disease, J Thorac Cardiovasc Surg, 135, 885, 10.1016/j.jtcvs.2007.11.039
Duran, 1994, Valve repair in rheumatic mitral disease: an unsolved problem, J Card Surg, 9, 282, 10.1111/j.1540-8191.1994.tb00942.x
Suri, 2009, Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse, J Thorac Cardiovasc Surg, 137, 1071, 10.1016/j.jtcvs.2008.10.026
Kang, 2009, Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation, Circulation, 119, 797, 10.1161/CIRCULATIONAHA.108.802314
Tribouilloy, 2011, Predicting left ventricular dysfunction after valve repair for mitral regurgitation due to leaflet prolapse: additive value of left ventricular end-systolic dimension to ejection fraction, Eur J Echocardiogr, 12, 702, 10.1093/ejechocard/jer128
Enriquez-Sarano, 2015, Is there an outcome penalty linked to guideline-based indications for valvular surgery? Early and long-term analysis of patients with organic mitral regurgitation, J Thorac Cardiovasc Surg, 150, 50, 10.1016/j.jtcvs.2015.04.009
Quintana, 2014, Left ventricular dysfunction after mitral valve repair—the fallacy of “normal” preoperative myocardial function, J Thorac Cardiovasc Surg, 148, 2752, 10.1016/j.jtcvs.2014.07.029
Suri, 2008, Determinants of early decline in ejection fraction after surgical correction of mitral regurgitation, J Thorac Cardiovasc Surg, 136, 442, 10.1016/j.jtcvs.2007.10.067
Naji, 2014, Importance of exercise capacity in predicting outcomes and determining optimal timing of surgery in significant primary mitral regurgitation, J Am Heart Assoc, 3, e001010, 10.1161/JAHA.114.001010
Cox, 1991, The surgical treatment of atrial fibrillation. IV. Surgical technique, J Thorac Cardiovasc Surg, 101, 584, 10.1016/S0022-5223(19)36685-1
Ghoreishi, 2011, Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery, J Thorac Cardiovasc Surg, 142, 1439, 10.1016/j.jtcvs.2011.08.030
Kawaguchi, 1996, Risks and benefits of combined maze procedure for atrial fibrillation associated with organic heart disease, J Am Coll Cardiol, 28, 985, 10.1016/S0735-1097(96)00275-6
Kobayashi, 1996, Rationale of the Cox Maze procedure for atrial fibrillation during redo mitral valve operations, J Thorac Cardiovasc Surg, 112, 1216, 10.1016/S0022-5223(96)70134-4
Ngaage, 2007, Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified?, Ann Thorac Surg, 84, 434, 10.1016/j.athoracsur.2007.04.036
Olasinska-Wisniewska, 2012, Impact of atrial remodeling on heart rhythm after radiofrequency ablation and mitral valve operations, Ann Thorac Surg, 93, 1449, 10.1016/j.athoracsur.2011.12.034
Raine, 2004, Effect of mitral valve repair/replacement surgery on atrial arrhythmia behavior, J Heart Valve Dis, 13, 615
Feldman, 2011, Percutaneous repair or surgery for mitral regurgitation, N Engl J Med, 364, 1395, 10.1056/NEJMoa1009355
Fattouch, 2009, POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial, J Thorac Cardiovasc Surg, 138, 278, 10.1016/j.jtcvs.2008.11.010
Whitlow, 2012, Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study, J Am Coll Cardiol, 59, 130, 10.1016/j.jacc.2011.08.067
Wu, 2005, Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction, J Am Coll Cardiol, 45, 381, 10.1016/j.jacc.2004.09.073
Asgar, 2015, Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations, J Am Coll Cardiol, 65, 1231, 10.1016/j.jacc.2015.02.009
Obadia, 2015, The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation, EuroIntervention, 10, 1354, 10.4244/EIJV10I11A232
Grigioni, 2001, Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment, Circulation, 103, 1759, 10.1161/01.CIR.103.13.1759
Lancellotti, 2005, Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation, Eur Heart J, 26, 1528, 10.1093/eurheartj/ehi189
Trichon, 2003, Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure, Am J Cardiol, 91, 538, 10.1016/S0002-9149(02)03301-5
Rossi, 2011, Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy, Heart, 97, 1675, 10.1136/hrt.2011.225789
Mihaljevic, 2007, Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation, J Am Coll Cardiol, 49, 2191, 10.1016/j.jacc.2007.02.043
Harris, 2002, Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve?, Ann Thorac Surg, 74, 1468, 10.1016/S0003-4975(02)03920-6
Benedetto, 2009, Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients, J Cardiovasc Med (Hagerstown), 10, 109, 10.2459/JCM.0b013e32831c84b0
Deja, 2012, Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial, Circulation, 125, 2639, 10.1161/CIRCULATIONAHA.111.072256
Cohn, 1995, The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement, Eur J Cardiothorac Surg, 9, 568, 10.1016/S1010-7940(05)80008-9
Chan, 2012, Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial, Circulation, 126, 2502, 10.1161/CIRCULATIONAHA.112.143818
Lim, 2013, Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair, J Am Coll Cardiol, 64, 182, 10.1016/j.jacc.2013.10.021
van Geldorp, 2009, Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk, J Thorac Cardiovasc Surg, 137, 881, 10.1016/j.jtcvs.2008.09.028
Glaser, 2016, Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years, Eur Heart J, 37, 2658, 10.1093/eurheartj/ehv580
Chikwe, 2015, Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years, JAMA, 313, 1435, 10.1001/jama.2015.3164
McClure, 2014, Late outcomes comparison of nonelderly patients with stented bioprosthetic and mechanical valves in the aortic position: a propensity-matched analysis, J Thorac Cardiovasc Surg, 148, 1931, 10.1016/j.jtcvs.2013.12.042
Chiang, 2014, Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years, JAMA, 312, 1323, 10.1001/jama.2014.12679
Repack, 2016, Comparison of quality of life perceived by patients with bioprosthetic versus mechanical valves after composite aortic root replacement, Cardiology, 133, 3, 10.1159/000438783
Dunning, 2011, Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use—an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database, J Thorac Cardiovasc Surg, 142, 776, 10.1016/j.jtcvs.2011.04.048
Rahimtoola, 2010, Choice of prosthetic heart valve in adults an update, J Am Coll Cardiol, 55, 2413, 10.1016/j.jacc.2009.10.085
Weber, 2012, Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age, J Thorac Cardiovasc Surg, 144, 1075, 10.1016/j.jtcvs.2012.01.024
Bourguignon, 2015, Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position, Ann Thorac Surg, 99, 831, 10.1016/j.athoracsur.2014.09.030
Bourguignon, 2014, Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations, J Thorac Cardiovasc Surg, 148, 2004, 10.1016/j.jtcvs.2014.02.050
Ye, 2015, Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an eight-year single-center experience, J Am Coll Cardiol Intv, 8, 1735, 10.1016/j.jcin.2015.08.012
Dvir, 2012, Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry, Circulation, 126, 2335, 10.1161/CIRCULATIONAHA.112.104505
Dvir, 2014, Transcatheter aortic valve implantation in failed bioprosthetic surgical valves, JAMA, 312, 162, 10.1001/jama.2014.7246
Hammermeister, 2000, Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial, J Am Coll Cardiol, 36, 1152, 10.1016/S0735-1097(00)00834-2
Chan, 2006, Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement, J Thorac Cardiovasc Surg, 131, 1267, 10.1016/j.jtcvs.2005.11.052
Kaneko, 2014, Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old, J Thorac Cardiovasc Surg, 147, 117, 10.1016/j.jtcvs.2013.08.028
Badhwar, 2012, Noninferiority of closely monitored mechanical valves to bioprostheses overshadowed by early mortality benefit in younger patients, Ann Thorac Surg, 93, 748, 10.1016/j.athoracsur.2011.12.032
Brown, 2008, Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses, J Thorac Cardiovasc Surg, 135, 878, 10.1016/j.jtcvs.2007.10.065
Kulik, 2006, Mechanical versus bioprosthetic valve replacement in middle-aged patients, Eur J Cardiothorac Surg, 30, 485, 10.1016/j.ejcts.2006.06.013
Bourguignon, 2015, Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 60 or younger, Ann Thorac Surg, 100, 853, 10.1016/j.athoracsur.2015.03.105
McClure, 2010, Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients, Ann Thorac Surg, 89, 1410, 10.1016/j.athoracsur.2010.01.046
Banbury, 2002, Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis, Ann Thorac Surg, 73, 1460, 10.1016/S0003-4975(02)03445-8
Borger, 2006, Twenty-year results of the Hancock II bioprosthesis, J Heart Valve Dis, 15, 49
Dellgren, 2002, Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis, J Thorac Cardiovasc Surg, 124, 146, 10.1067/mtc.2002.121672
Mykén, 2009, A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis, J Thorac Cardiovasc Surg, 137, 76, 10.1016/j.jtcvs.2008.05.068
Charitos, 2012, Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: an update on the German Dutch Ross Registry, J Thorac Cardiovasc Surg, 144, 813, 10.1016/j.jtcvs.2012.07.005
El-Hamamsy, 2010, Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial, Lancet, 376, 524, 10.1016/S0140-6736(10)60828-8
Mokhles, 2012, Autograft and pulmonary allograft performance in the second post-operative decade after the Ross procedure: insights from the Rotterdam Prospective Cohort Study, Eur Heart J, 33, 2213, 10.1093/eurheartj/ehs173
Edmunds, 1987, Thrombotic and bleeding complications of prosthetic heart valves, Ann Thorac Surg, 44, 430, 10.1016/S0003-4975(10)63816-7
Tiede, 1998, Modern management of prosthetic valve anticoagulation, Mayo Clin Proc, 73, 665, 10.1016/S0025-6196(11)64893-3
Aziz, 2011, Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care, J Vasc Surg, 54, 1404, 10.1016/j.jvs.2011.05.021
Chiquette, 1998, Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs, Arch Intern Med, 158, 1641, 10.1001/archinte.158.15.1641
Wittkowsky, 2006, Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting, Chest, 130, 1385, 10.1378/chest.130.5.1385
Lalonde, 2008, Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial, Am Heart J, 156, 148, 10.1016/j.ahj.2008.02.009
Witt, 2005, Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy, Chest, 127, 1515, 10.1378/chest.127.5.1515
Locke, 2005, Reduction in warfarin adverse events requiring patient hospitalization after implementation of a pharmacist-managed anticoagulation service, Pharmacotherapy, 25, 685, 10.1592/phco.25.5.685.63582
Whitlock, 2012, Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e576S, 10.1378/chest.11-2305
Cannegieter, 1994, Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses, Circulation, 89, 635, 10.1161/01.CIR.89.2.635
Cannegieter, 1995, Optimal oral anticoagulant therapy in patients with mechanical heart valves, N Engl J Med, 333, 11, 10.1056/NEJM199507063330103
Schlitt, 2003, Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA), Thromb Res, 109, 131, 10.1016/S0049-3848(03)00143-9
Stein, 2001, Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves, Chest, 119, 220S, 10.1378/chest.119.1_suppl.220S
Sun, 2009, Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends, Lancet, 374, 565, 10.1016/S0140-6736(09)60780-7
Acar, 1996, AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves, Circulation, 94, 2107, 10.1161/01.CIR.94.9.2107
Hering, 2005, Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study, Chest, 127, 53, 10.1378/chest.127.1.53
Torella, 2010, LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the “LOWERING-IT” Trial, Am Heart J, 160, 171, 10.1016/j.ahj.2010.05.005
Horstkotte, 1995, Intracardiac thrombosis: patient-related and device-related factors, J Heart Valve Dis, 4, 114
Pruefer, 2001, Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5), Eur Heart J Suppl, 3, Q39, 10.1016/S1520-765X(01)90041-0
Meschengieser, 1997, Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves, J Thorac Cardiovasc Surg, 113, 910, 10.1016/S0022-5223(97)70264-2
Turpie, 1993, A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement, N Engl J Med, 329, 524, 10.1056/NEJM199308193290802
Aramendi, 2005, Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial, Eur J Cardiothorac Surg, 27, 854, 10.1016/j.ejcts.2004.12.064
Colli, 2007, Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial, J Heart Valve Dis, 16, 667
Heras, 1995, High risk of thromboemboli early after bioprosthetic cardiac valve replacement, J Am Coll Cardiol, 25, 1111, 10.1016/0735-1097(94)00563-6
Nuñez, 1984, Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis, Ann Thorac Surg, 37, 84, 10.1016/S0003-4975(10)60717-5
Brennan, 2012, Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database, J Am Coll Cardiol, 60, 971, 10.1016/j.jacc.2012.05.029
Egbe, 2015, Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors, J Am Coll Cardiol, 66, 2285, 10.1016/j.jacc.2015.09.022
Mérie, 2012, Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding, JAMA, 308, 2118, 10.1001/jama.2012.54506
Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561
Douketis, 2015, Perioperative bridging anticoagulation in patients with atrial fibrillation, N Engl J Med, 373, 823, 10.1056/NEJMoa1501035
Eikelboom, 2013, Dabigatran versus warfarin in patients with mechanical heart valves, N Engl J Med, 369, 1206, 10.1056/NEJMoa1300615
Giugliano, 2013, Edoxaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 369, 2093, 10.1056/NEJMoa1310907
Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 365, 981, 10.1056/NEJMoa1107039
Makkar, 2015, Possible subclinical leaflet thrombosis in bioprosthetic aortic valves, N Engl J Med, 373, 2015, 10.1056/NEJMoa1509233
Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638
Sundt, 2005, Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?, J Thorac Cardiovasc Surg, 129, 1024, 10.1016/j.jtcvs.2004.11.028
Russo, 2008, Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications, J Am Coll Cardiol, 51, 1203, 10.1016/j.jacc.2007.10.058
ElBardissi, 2010, Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?, J Thorac Cardiovasc Surg, 139, 1137, 10.1016/j.jtcvs.2009.10.064
Levine, 2016, 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, 68, 1082, 10.1016/j.jacc.2016.03.513
Puskas, 2014, Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized On-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial, J Thorac Cardiovasc Surg, 147, 1202, 10.1016/j.jtcvs.2014.01.004
Hansson, 2016, Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications, J Am Coll Cardiol, 68, 2059, 10.1016/j.jacc.2016.08.010
Pache, 2016, Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves, Eur Heart J, 37, 2263, 10.1093/eurheartj/ehv526
FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves. December 19, 2012. 2012.
Van de Werf, 2012, A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN), Am Heart J, 163, 931, 10.1016/j.ahj.2012.03.011
Douketis, 2012, Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Erratum, Chest, 141, e326S, 10.1378/chest.11-2298
Barbetseas, 1998, Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters, J Am Coll Cardiol, 32, 1410, 10.1016/S0735-1097(98)00385-4
Gündüz, 2015, Sixty-four-section cardiac computed tomography in mechanical prosthetic heart valve dysfunction: thrombus or pannus, Circ Cardiovasc Imaging, 8, e003246, 10.1161/CIRCIMAGING.115.003246
Cianciulli, 2005, Cinefluoroscopic assessment of mechanical disc prostheses: its value as a complementary method to echocardiography, J Heart Valve Dis, 14, 664
Montorsi, 2000, Role of cine-fluoroscopy, transthoracic, and transesophageal echocardiography in patients with suspected prosthetic heart valve thrombosis, Am J Cardiol, 85, 58, 10.1016/S0002-9149(99)00607-4
Muratori, 2006, Feasibility and diagnostic accuracy of quantitative assessment of mechanical prostheses leaflet motion by transthoracic and transesophageal echocardiography in suspected prosthetic valve dysfunction, Am J Cardiol, 97, 94, 10.1016/j.amjcard.2005.07.112
Suh, 2016, Added value of cardiac computed tomography for evaluation of mechanical aortic valve: emphasis on evaluation of pannus with surgical findings as standard reference, Int J Cardiol, 214, 454, 10.1016/j.ijcard.2016.04.011
Symersky, 2009, Comparison of multidetector-row computed tomography to echocardiography and fluoroscopy for evaluation of patients with mechanical prosthetic valve obstruction, Am J Cardiol, 104, 1128, 10.1016/j.amjcard.2009.05.061
Gürsoy, 2013, The incremental value of RT three-dimensional TEE in the evaluation of prosthetic mitral valve ring thrombosis complicated with thromboembolism, Echocardiography, 30, E198, 10.1111/echo.12246
Tong, 2004, Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry, J Am Coll Cardiol, 43, 77, 10.1016/j.jacc.2003.08.028
Keuleers, 2011, Comparison of thrombolysis versus surgery as a first line therapy for prosthetic heart valve thrombosis, Am J Cardiol, 107, 275, 10.1016/j.amjcard.2010.09.013
Roudaut, 2009, Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases, Arch Cardiovasc Dis, 102, 269, 10.1016/j.acvd.2009.01.007
Karthikeyan, 2009, Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial, Circulation, 120, 1108, 10.1161/CIRCULATIONAHA.109.876706
Cáceres-Lóriga, 2006, Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients, J Thromb Thrombolysis, 21, 185, 10.1007/s11239-006-4969-y
Özkan, 2013, Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial, J Am Coll Cardiol Img, 6, 206, 10.1016/j.jcmg.2012.10.016
Nagy, 2009, Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events, J Heart Valve Dis, 18, 268
Özkan, 2013, Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator, Circulation, 128, 532, 10.1161/CIRCULATIONAHA.113.001145
Deviri, 1991, Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management, J Am Coll Cardiol, 17, 646, 10.1016/S0735-1097(10)80178-0
Karthikeyan, 2013, Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies, Eur Heart J, 34, 1557, 10.1093/eurheartj/ehs486
Huang, 2013, Treatment of obstructive thrombosed prosthetic heart valve, J Am Coll Cardiol, 62, 1731, 10.1016/j.jacc.2013.07.075
Özkan, 2015, Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial, Am Heart J, 170, 409, 10.1016/j.ahj.2015.04.025
Laschinger, 2015, Reduced leaflet motion in bioprosthetic aortic valves—the FDA perspective, N Engl J Med, 373, 1996, 10.1056/NEJMp1512264
Pibarot, 2009, Prosthetic heart valves: selection of the optimal prosthesis and long-term management, Circulation, 119, 1034, 10.1161/CIRCULATIONAHA.108.778886
Koene, 2013, Impact of prosthesis-patient mismatch on early and late mortality after aortic valve replacement, J Cardiothorac Surg, 8, 96, 10.1186/1749-8090-8-96
Maganti, 2009, Redo valvular surgery in elderly patients, Ann Thorac Surg, 87, 521, 10.1016/j.athoracsur.2008.09.030
Leontyev, 2011, Redo aortic valve surgery: early and late outcomes, Ann Thorac Surg, 91, 1120, 10.1016/j.athoracsur.2010.12.053
Kaneko, 2015, Contemporary outcomes of repeat aortic valve replacement: a benchmark for transcatheter valve-in-valve procedures, Ann Thorac Surg, 100, 1298, 10.1016/j.athoracsur.2015.04.062
Jander, 2012, Usefulness of phenprocoumon for the treatment of obstructing thrombus in bioprostheses in the aortic valve position, Am J Cardiol, 109, 257, 10.1016/j.amjcard.2011.08.038
Butnaru, 2013, Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation, Am J Cardiol, 112, 1439, 10.1016/j.amjcard.2013.06.014
Pislaru, 2015, Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series, Eur J Cardiothorac Surg, 47, 725, 10.1093/ejcts/ezu201
De Marchena, 2015, Thrombus formation following transcatheter aortic valve replacement, J Am Coll Cardiol Intv, 8, 728, 10.1016/j.jcin.2015.03.005
Latib, 2015, Treatment and clinical outcomes of transcatheter heart valve thrombosis, Circ Cardiovasc Interv, 8, 10.1161/CIRCINTERVENTIONS.114.001779
Webb, 2010, Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves, Circulation, 121, 1848, 10.1161/CIRCULATIONAHA.109.924613
Phan, 2016, Transcatheter valve-in-valve implantation versus reoperative conventional aortic valve replacement: a systematic review, J Thorac Dis, 8, E83
Administration USFaD. FDA expands use of CoreValue System for aortic “valve-in-valve replacement”. March 30, 2015. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm440535.htm. Accessed January 20, 2017.
Akins, 2005, Early and late results of the surgical correction of cardiac prosthetic paravalvular leaks, J Heart Valve Dis, 14, 792
Miller, 1995, Reoperation for aortic valve periprosthetic leakage: identification of patients at risk and results of operation, J Heart Valve Dis, 4, 160
Ruiz, 2011, Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks, J Am Coll Cardiol, 58, 2210, 10.1016/j.jacc.2011.03.074
Sorajja, 2011, Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients, Circ Cardiovasc Interv, 4, 314, 10.1161/CIRCINTERVENTIONS.110.960955
Sorajja, 2011, Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation, J Am Coll Cardiol, 58, 2218, 10.1016/j.jacc.2011.07.041
Botelho-Nevers, 2009, Dramatic reduction in infective endocarditis-related mortality with a management-based approach, Arch Intern Med, 169, 1290, 10.1001/archinternmed.2009.192
Gordon, 2000, Early onset prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997, Ann Thorac Surg, 69, 1388, 10.1016/S0003-4975(00)01135-8
Hasbun, 2003, Complicated left-sided native valve endocarditis in adults: risk classification for mortality, JAMA, 289, 1933, 10.1001/jama.289.15.1933
Jault, 1997, Active native valve endocarditis: determinants of operative death and late mortality, Ann Thorac Surg, 63, 1737, 10.1016/S0003-4975(97)00117-3
Kiefer, 2011, Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure, JAMA, 306, 2239, 10.1001/jama.2011.1701
Tornos, 1992, Late prosthetic valve endocarditis. Immediate and long-term prognosis, Chest, 101, 37, 10.1378/chest.101.1.37
Wang, 2007, Contemporary clinical profile and outcome of prosthetic valve endocarditis, JAMA, 297, 1354, 10.1001/jama.297.12.1354
Aksoy, 2007, Early surgery in patients with infective endocarditis: a propensity score analysis, Clin Infect Dis, 44, 364, 10.1086/510583
Chirouze, 2004, Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database, Clin Infect Dis, 38, 1323, 10.1086/383035
Ellis, 2001, Fungal endocarditis: evidence in the world literature, 1965-1995, Clin Infect Dis, 32, 50, 10.1086/317550
Hill, 2007, Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study, Eur Heart J, 28, 196, 10.1093/eurheartj/ehl427
Melgar, 1997, Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital, Medicine (Baltimore), 76, 94, 10.1097/00005792-199703000-00002
Remadi, 2007, Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis, Ann Thorac Surg, 83, 1295, 10.1016/j.athoracsur.2006.09.093
Wolff, 1995, Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision, Chest, 108, 688, 10.1378/chest.108.3.688
Anguera, 2005, Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality, Eur Heart J, 26, 288, 10.1093/eurheartj/ehi034
Chan, 2002, Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess, CMAJ, 167, 19
Jault, 1993, Prosthetic valve endocarditis with ring abscesses. Surgical management and long-term results, J Thorac Cardiovasc Surg, 105, 1106, 10.1016/S0022-5223(19)33785-7
Middlemost, 1991, A case for early surgery in native left-sided endocarditis complicated by heart failure: results in 203 patients, J Am Coll Cardiol, 18, 663, 10.1016/0735-1097(91)90785-8
Wang, 1972, Complete heart block complicating bacterial endocarditis, Circulation, 46, 939, 10.1161/01.CIR.46.5.939
Hill, 2007, Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study, Am Heart J, 154, 923, 10.1016/j.ahj.2007.06.028
Klieverik, 2009, Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses, Ann Thorac Surg, 88, 1814, 10.1016/j.athoracsur.2009.08.019
Manne, 2012, Outcomes after surgical treatment of native and prosthetic valve infective endocarditis, Ann Thorac Surg, 93, 489, 10.1016/j.athoracsur.2011.10.063
Athan, 2012, Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices, JAMA, 307, 1727, 10.1001/jama.2012.497
Ho, 2010, Prosthetic valve endocarditis in a multicenter registry of Chinese patients, Asian Cardiovasc Thorac Ann, 18, 430, 10.1177/0218492310379457
Rundström, 2004, Pacemaker endocarditis during 18 years in Göteborg, Scand J Infect Dis, 36, 674, 10.1080/00365540410022611
Sohail, 2008, Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection, Mayo Clin Proc, 83, 46, 10.4065/83.1.46
Kang, 2012, Early surgery versus conventional treatment for infective endocarditis, N Engl J Med, 366, 2466, 10.1056/NEJMoa1112843
Mügge, 1989, Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach, J Am Coll Cardiol, 14, 631, 10.1016/0735-1097(89)90104-6
Thuny, 2005, Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study, Circulation, 112, 69, 10.1161/CIRCULATIONAHA.104.493155
Eishi, 1995, Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan, J Thorac Cardiovasc Surg, 110, 1745, 10.1016/S0022-5223(95)70038-2
Barsic, 2013, Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke, Clin Infect Dis, 56, 209, 10.1093/cid/cis878